According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Image source: Compass. Revenue soared 25.9% in Q4 to $1.38 billion ...

The phenomenal stock price rally underscores ... 77.6% against the industry’s 7.1% decline. Image Source: Zacks Investment Research Compass Therapeutics is on track to report top-line data ...

Compass Group PLC closed 8.34% below its 52-week high of £28.53, which the company reached on February 18th.

Shares of Compass Therapeutics (NASDAQ:CMPX) were up 8% in afternoon trading Monday after Guggenheim initiated coverage of the stock with a buy rating ahead of upcoming data for the company's drug ...

If Compass can reach GAAP profitability, it could have a lot of upside. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now ...

Compass posted strong growth in its fourth-quarter ... According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Revenue soared 25.9 ...

Shares of Compass (NYSE: COMP), the nation's largest ... On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about ...